Video Shorts

1:15
Market Watch Rx: West Pharmaceutical Services Leads Gainers
3 months ago
by
Nicholas Jacobus

0:32
Why 'Just-In-Time' Delivery is a Trap
3 months ago
by
Nicholas Jacobus(+1 more)

0:29
The United State's Regulatory Impact on Global Drug Launches
3 months ago
by
Mike Hollan(+1 more)

1:08
Market Watch Rx: Johnson & Johnson Shares Slide
3 months ago
by
Nicholas Jacobus

0:40
Real Hope: The Best Part of Being an Oncologist
3 months ago
by
Nicholas Jacobus(+1 more)

0:46
How Platform Technologies and Partnerships are Shaping CGT Development
3 months ago
by
Mike Hollan(+1 more)

0:43
Branding's Hidden Power
3 months ago
by
Michael Christel(+1 more)

1:09
Market Watch Rx: Roche Joins Top Gainers
3 months ago
by
Nicholas Jacobus

0:42
Addressing the Biosimilar Void in the U.S. Market
3 months ago
by
Mike Hollan(+1 more)

1:13
Market Watch Rx: Humana Leads Gainers
4 months ago
by
Nicholas Jacobus

0:40
The Relationship Between Muscle Building and GLP-1s
4 months ago
by
Mike Hollan(+1 more)

0:56
Drug Policy Shift: MFN's Impact on Providers
4 months ago
by
Mike Hollan(+1 more)

0:50
The Weird Connection Between Cancer and Heart Attacks
4 months ago

1:01
Market Watch Rx: Merck Joins Top Gainers
4 months ago
by
Nicholas Jacobus

0:50
Why China’s R&D Model is Thriving
4 months ago
by
Michael Christel(+2 more)

0:34
Takeaways from Day One at Access USA 2026
4 months ago
by
Nicholas Jacobus(+1 more)

1:01
Market Watch Rx: Intellia Therapeutics Leads Gainers
4 months ago
by
Nicholas Jacobus

1:08
What You Need to Know: MFN, Healthcare Spending, and Compounded Medications
4 months ago
by
Mike Hollan

0:42
What Can Help Patient Support Operations?
4 months ago
by
Nicholas Jacobus(+1 more)

1:41
2026 Drug Pipeline Report
4 months ago
by
Michael Christel

0:51
Measuring Good Patient Access from Bad Patient Access
4 months ago
by
Nicholas Jacobus(+1 more)

0:30
Can't Afford Your Meds? Watch This
4 months ago
by
Nicholas Jacobus(+1 more)

1:05
Market Watch Rx: Pfizer Joins Top Gainers
4 months ago
by
Nicholas Jacobus

1:03
Measuring the AI Bubble
5 months ago
by
Michael Christel(+2 more)

0:59
Market Watch Rx: IQVIA Joins Top Gainers
5 months ago
by
Nicholas Jacobus

0:53
FDA Drops Two-Trial Rule for New Drugs
5 months ago
by
Nicholas Jacobus(+1 more)

0:51
Market Watch Rx: Moderna Remains Amongst Top Gainers
5 months ago
by
Nicholas Jacobus

0:38
Europe’s Innovation Edge?
5 months ago
by
Michael Christel(+1 more)

0:53
Future of Healthcare: Hybrid Drug Payment System
5 months ago
by
Nicholas Jacobus(+1 more)

1:03
Market Watch Rx: Moderna Leads Gainers
5 months ago
by
Nicholas Jacobus
Advertisement
Advertisement
Trending on PharmExec
1
FDA Pannel Votes to Loosen Restrictions for Four Peptides
2
Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides
3
President Trump Announces Phased Generic Drug Tariff Plan: Report
4
The Business Case for Employer-Based GLP-1 Coverage
5
